Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Judith A Smith

Showing results (111-120 of 142) with videos related to

Pageof 15
Sort By:
Cancer|February 26, 2009
Phase 2 trial of mifepristone (RU-486) in advanced or recurrent endometrioid adenocarcinoma or low-grade endometrial stromal sarcomaLois M Ramondetta, Alaina J Johnson, Charlotte C Sun, et al.
Journal of Immunology (Baltimore, Md. : 1950)|August 6, 2005
HLA-B27 misfolding in transgenic rats is associated with activation of the unfolded protein responseMatthew J Turner, Dawn P Sowders, Monica L DeLay, et al.
Pharmacotherapy|June 29, 2006
The state of science and research in clinical pharmacy, Susan C Fagan, Daniel Touchette, et al.
Supportive Care in Cancer : Official Journal of the Multinational Association of Supportive Care in Cancer|November 13, 2004
Rankings and symptom assessments of side effects from chemotherapy: insights from experienced patients with ovarian cancerCharlotte C Sun, Diane C Bodurka, Candice B Weaver, et al.
Mayo Clinic Proceedings|April 3, 2009
Comprehensive diagnostic program for medically underserved women with abnormal breast screening evaluations in an urban populationFrances M Palmieri, Elizabeth R DePeri, Betty A Mincey, et al.
Arthritis & Rheumatology (Hoboken, N.J.)|April 24, 2014
Reverse interferon signature is characteristic of antigen-presenting cells in human and rat spondyloarthritisIngrid Fert, Nicolas Cagnard, Simon Glatigny, et al.
Frontiers in Oncology|April 6, 2019
<i>From Bench to Bedside</i>: Evaluation of AHCC Supplementation to Modulate the Host Immunity to Clear High-Risk Human Papillomavirus InfectionsJudith A Smith, Lata Mathew, Anjali Gaikwad, et al.
The Journal of Animal Ecology|February 8, 2025
Combining in vivo and in vitro approaches to better understand host-pathogen nutritional interactionsRobert Holdbrook, Catherine E Reavey, Joanna L Randall, et al.
Pharmacotherapy|December 13, 2016
White Paper on Natural ProductsMichael Gabay, Judith A Smith, Mary L Chavez, et al.
Infection and Immunity|September 28, 2016
The Bacterial Second Messenger Cyclic di-GMP Regulates Brucella Pathogenesis and Leads to Altered Host Immune ResponseMike Khan, Jerome S Harms, Fernanda M Marim, et al.
Pageof 15

Showing results (111-120 of 142) with videos related to

Sort By:
Pageof 15
Cancer|February 26, 2009
Phase 2 trial of mifepristone (RU-486) in advanced or recurrent endometrioid adenocarcinoma or low-grade endometrial stromal sarcomaLois M Ramondetta, Alaina J Johnson, Charlotte C Sun, et al.
Journal of Immunology (Baltimore, Md. : 1950)|August 6, 2005
HLA-B27 misfolding in transgenic rats is associated with activation of the unfolded protein responseMatthew J Turner, Dawn P Sowders, Monica L DeLay, et al.
Pharmacotherapy|June 29, 2006
The state of science and research in clinical pharmacy, Susan C Fagan, Daniel Touchette, et al.
Supportive Care in Cancer : Official Journal of the Multinational Association of Supportive Care in Cancer|November 13, 2004
Rankings and symptom assessments of side effects from chemotherapy: insights from experienced patients with ovarian cancerCharlotte C Sun, Diane C Bodurka, Candice B Weaver, et al.
Mayo Clinic Proceedings|April 3, 2009
Comprehensive diagnostic program for medically underserved women with abnormal breast screening evaluations in an urban populationFrances M Palmieri, Elizabeth R DePeri, Betty A Mincey, et al.
Arthritis & Rheumatology (Hoboken, N.J.)|April 24, 2014
Reverse interferon signature is characteristic of antigen-presenting cells in human and rat spondyloarthritisIngrid Fert, Nicolas Cagnard, Simon Glatigny, et al.
Frontiers in Oncology|April 6, 2019
<i>From Bench to Bedside</i>: Evaluation of AHCC Supplementation to Modulate the Host Immunity to Clear High-Risk Human Papillomavirus InfectionsJudith A Smith, Lata Mathew, Anjali Gaikwad, et al.
The Journal of Animal Ecology|February 8, 2025
Combining in vivo and in vitro approaches to better understand host-pathogen nutritional interactionsRobert Holdbrook, Catherine E Reavey, Joanna L Randall, et al.
Pharmacotherapy|December 13, 2016
White Paper on Natural ProductsMichael Gabay, Judith A Smith, Mary L Chavez, et al.
Infection and Immunity|September 28, 2016
The Bacterial Second Messenger Cyclic di-GMP Regulates Brucella Pathogenesis and Leads to Altered Host Immune ResponseMike Khan, Jerome S Harms, Fernanda M Marim, et al.
Pageof 15